Bridging Dermatology and Medical Oncology: Immunotherapy in Cutaneous Squamous Cell Carcinoma
At the forefront of the evolving treatment landscape for cutaneous squamous cell carcinoma (cSCC), Dr. David M. Miller—a board-certified internist, dermatologist, and medical oncologist at Massachusetts General Hospital—delivered a highly informative lecture on the past, present, and future of immunotherapy for cSCC at ODAC 2025. With his unique expertise across three disciplines, Dr. Miller e …
At the forefront of the evolving treatment landscape for cutaneous squamous cell carcinoma (cSCC), Dr. David M. Miller—a board-certified internist, dermatologist, and medical oncologist at Massachusetts General Hospital—delivered a highly informative lecture on the past, present, and future of immunotherapy for cSCC at ODAC 2025. With his unique expertise across three disciplines, Dr. Miller e … 
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patient with vitiligo, is thought to be decreased. This report presents a case of melanoma developing on a non-sun-exposed site in a patient with skin of color and untreated vitiligo. It emphasizes the need … 
Dr. John Harris, professor and chair of the dermatology department at UMass Chan Medical School, shared current challenges and knowledge gaps in treating pigmentary disorders in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains how these knowledge gaps impact the patient’s experience, including their expectations of vi … 
Delivering effective dermatologic care for patients with skin of color requires a deep understanding of their unique needs. In her presentation at the Skin of Color Update, Dr. Amy McMichael, professor in the Department of Dermatology at Wake Forest School of Medicine, shared practical insights on managing non-scarring alopecia, emphasizing the importance of considering both biological and cultura … 
Health recently wrote an article detailing laser hair removal as a treatment option for hidradenitis suppurativa (HS). What role does laser hair removal play in an HS treatment plan, and which patients make good candidates? For an expert’s perspective, I reached out to Steven Daveluy, MD, FAAD, professor and program director at Wayne State Dermatology.
In your practice, what role does laser hai …